bioMérieux S.A.
EPA:BIM.PA
106.6 (EUR) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,674.7 | 3,589.1 | 3,376.2 | 3,118.2 | 2,674.8 | 2,421.3 | 2,288.2 | 2,103.2 | 1,964.6 | 1,698.4 | 1,587.9 | 1,569.8 | 1,427.2 | 1,357 | 1,223.4 | 1,110.5 | 1,062.8 | 1,036.9 | 993.6 |
| Cost of Revenue
| 1,788 | 1,628 | 1,406.8 | 1,382 | 1,226.1 | 1,119 | 1,076.4 | 1,002.5 | 975.4 | 853.9 | 763.3 | 755.6 | 666.1 | 634.9 | 563.8 | 517.5 | 497 | 495 | 473.2 |
| Gross Profit
| 1,886.7 | 1,961.1 | 1,969.4 | 1,736.2 | 1,448.7 | 1,302.3 | 1,211.8 | 1,100.7 | 989.2 | 844.5 | 824.6 | 814.2 | 761.1 | 722.1 | 659.6 | 593 | 565.8 | 541.9 | 520.4 |
| Gross Profit Ratio
| 0.513 | 0.546 | 0.583 | 0.557 | 0.542 | 0.538 | 0.53 | 0.523 | 0.504 | 0.497 | 0.519 | 0.519 | 0.533 | 0.532 | 0.539 | 0.534 | 0.532 | 0.523 | 0.524 |
| Reseach & Development Expenses
| 460.1 | 446.6 | 385.8 | 395.7 | 372.5 | 367.7 | 304.4 | 271.9 | 238.9 | 205.8 | 191.8 | 168.7 | 152.1 | 149.2 | 143 | 132.7 | 131.8 | 129.6 | 130.7 |
| General & Administrative Expenses
| 295 | 253.2 | 242.1 | 200 | 182.2 | 163.2 | 156.4 | 167.4 | 163.8 | 141.7 | 121.4 | 114.3 | 107.6 | 103.2 | 98.7 | 87.1 | 88.3 | -100.7 | -95.4 |
| Selling & Marketing Expenses
| 725.5 | 701.5 | 573.5 | 589.3 | 567.6 | 479.9 | 447.5 | 402.1 | 365.4 | 311.3 | 283.2 | 294.7 | 264.5 | 238.8 | 217.1 | 198.9 | 189.3 | 186.7 | 177.3 |
| SG&A
| 1,020.5 | 954.7 | 815.6 | 789.3 | 749.8 | 643.1 | 603.9 | 569.5 | 529.2 | 453 | 404.6 | 409 | 372.1 | 342 | 315.8 | 286 | 277.6 | 86 | 81.9 |
| Other Expenses
| 33 | 0 | 0 | 50.5 | 4.5 | 1.8 | 1.6 | 1.2 | 2 | 0 | 0 | -23.9 | -20.7 | -13.1 | -2.9 | -0.8 | 1.4 | 2.8 | 169 |
| Operating Expenses
| 1,447.6 | 1,401.3 | 1,201.4 | 1,185 | 1,117.8 | 963.3 | 904.9 | 826.2 | 797.8 | 650.2 | 580.3 | 553.8 | 503.5 | 478.1 | 455.9 | 406.1 | 398.8 | 392.5 | 381.6 |
| Operating Income
| 439.1 | 559.8 | 768 | 551.2 | 330.9 | 363.5 | 334.7 | 297.8 | 260 | 226.8 | 262.4 | 235 | 245.4 | 244 | 203.7 | 186.1 | 149.9 | 152.5 | 138.9 |
| Operating Income Ratio
| 0.119 | 0.156 | 0.227 | 0.177 | 0.124 | 0.15 | 0.146 | 0.142 | 0.132 | 0.134 | 0.165 | 0.15 | 0.172 | 0.18 | 0.167 | 0.168 | 0.141 | 0.147 | 0.14 |
| Total Other Income Expenses Net
| -1.8 | -9.6 | -19.7 | -56.8 | -12.3 | -43 | -42.7 | -38.8 | -83.8 | -39.6 | -19.3 | -11.3 | -7.6 | -2.6 | -1.1 | -3.3 | 4.7 | -0.5 | -0.4 |
| Income Before Tax
| 437.3 | 550.2 | 748.3 | 494.4 | 318.6 | 320.5 | 292 | 259 | 176.2 | 187.2 | 243.1 | 223.7 | 237.8 | 241.4 | 202.6 | 182.8 | 154.6 | 152 | 138.5 |
| Income Before Tax Ratio
| 0.119 | 0.153 | 0.222 | 0.159 | 0.119 | 0.132 | 0.128 | 0.123 | 0.09 | 0.11 | 0.153 | 0.143 | 0.167 | 0.178 | 0.166 | 0.165 | 0.145 | 0.147 | 0.139 |
| Income Tax Expense
| 114.5 | 109.7 | 149.4 | 91.5 | 48.9 | 65.1 | 54.5 | 79.8 | 65.9 | 51.7 | 78.4 | 89.4 | 77.3 | 81.4 | 54.4 | 51.5 | 55.1 | 46.6 | 48.4 |
| Net Income
| 357.6 | 452.4 | 601.1 | 404.4 | 272.8 | 256.6 | 238.1 | 179.1 | 110.5 | 134.9 | 164.3 | 134.4 | 160.5 | 160 | 148.2 | 130 | 98.1 | 105.3 | 90.1 |
| Net Income Ratio
| 0.097 | 0.126 | 0.178 | 0.13 | 0.102 | 0.106 | 0.104 | 0.085 | 0.056 | 0.079 | 0.103 | 0.086 | 0.112 | 0.118 | 0.121 | 0.117 | 0.092 | 0.102 | 0.091 |
| EPS
| 3.03 | 3.84 | 5.08 | 3.42 | 2.31 | 2.18 | 2.02 | 1.51 | 0.93 | 1.14 | 1.39 | 1.14 | 1.34 | 1.34 | 1.25 | 1.1 | 0.83 | 0.89 | 0.76 |
| EPS Diluted
| 3.01 | 3.82 | 5.06 | 3.41 | 2.3 | 2.17 | 2.01 | 1.51 | 0.93 | 1.14 | 1.39 | 1.14 | 1.34 | 1.34 | 1.25 | 1.1 | 0.83 | 0.89 | 0.76 |
| EBITDA
| 828.1 | 817.4 | 988.4 | 779.6 | 538.4 | 519.2 | 475 | 438.7 | 383.9 | 332.8 | 344.4 | 331.1 | 343.1 | 332.9 | 264 | 258 | 262.2 | 207.9 | 210.3 |
| EBITDA Ratio
| 0.225 | 0.228 | 0.293 | 0.25 | 0.201 | 0.214 | 0.208 | 0.209 | 0.195 | 0.196 | 0.217 | 0.211 | 0.24 | 0.245 | 0.216 | 0.232 | 0.247 | 0.201 | 0.212 |